{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:19:00Z","timestamp":1773166740948,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.nucmedbio.2020.07.004","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T12:21:48Z","timestamp":1594902108000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Radiosynthesis and evaluation of 18F-labeled dopamine D4-receptor ligands"],"prefix":"10.1016","volume":"92","author":[{"given":"Michael","family":"Willmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Ermert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Prante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gmeiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Neumaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0165-6147(92)90041-4","article-title":"Developments in the drug treatment of schizophrenia","volume":"13","author":"Reynolds","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3956(96)00039-8","article-title":"Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action","volume":"31","author":"Sanyal","year":"1997","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0015","series-title":"Advances in pharmacology","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-420118-7.00008-1","article-title":"Chapter eight-dopamine D4 receptors in Psychostimulant addiction","author":"Di Ciano","year":"2014"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0020","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/00004583-200012000-00017","article-title":"Linkage of the dopamine D4 receptor gene and attention-deficit\/hyperactivity disorder","volume":"39","author":"Sunohara","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0025","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/350610a0","article-title":"Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine","volume":"350","author":"Van Tol","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0030","first-page":"1","article-title":"Dopamine Receptors","author":"Strange","year":"2013"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0035","unstructured":"Roth B, Lopez E, PDSP Ki database. Psychoactive drug screening program (PDSP). (Accessed 15.07.2019); Available online: https:\/\/pdsp.unc.edu\/databases\/kidb.php."},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0040","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0045","first-page":"137","article-title":"The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system","volume":"4","author":"O\u2019Malley","year":"1992","journal-title":"New Biol"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0893-133X(95)00150-C","article-title":"Dopamine receptor mRNA expression in human striatum and Neocortex","volume":"15","author":"Meador-Woodruff","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0055","first-page":"1156","article-title":"Antipsychotische Wirksamkeit im Verh\u00e4ltnis zum Plasmaspiegel von Clozapin. Arzneimittelforschung","volume":"26","author":"Ackenheil","year":"1976","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/archpsyc.1997.01830180085011","article-title":"The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia","volume":"54","author":"Kramer","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1176\/ajp.156.3.419","article-title":"Placebo-controlled study of the D4\/5-HT2A antagonist Fananserin in the treatment of schizophrenia","volume":"156","author":"Truffinet","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.82.1","article-title":"Dopamine D4 receptors","volume":"82","author":"Helmeste","year":"2000","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1096-9861(19981221)402:3<353::AID-CNE5>3.0.CO;2-4","article-title":"Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain","volume":"402","author":"Khan","year":"1998","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0080","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/jm001055e","article-title":"Comparative molecular field analysis of dopamine D4 receptor antagonists including 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 113), 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]-1H-pyrrolo[2,3-b]pyridine (L-745,870), and clozapine","volume":"44","author":"Lanig","year":"2001","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.nucmedbio.2020.07.004_bb0085","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1124\/mol.104.001321","article-title":"Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D4 receptor interact with a common receptor microdomain","volume":"66","author":"Kortagere","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0090","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1124\/dmd.112.046599","article-title":"Nonspecific protein binding versus membrane partitioning-it is not just semantics","volume":"40","author":"Nagar","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/JMN:20:3:255","article-title":"Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives","volume":"20","author":"Wang","year":"2003","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0100","doi-asserted-by":"crossref","first-page":"T56","DOI":"10.1016\/j.neuroimage.2006.04.047","article-title":"To lipophilicity and beyond\u2014towards a deeper understanding of radioligand non-specific binding","volume":"31","author":"Sebai","year":"2006","journal-title":"NeuroImage"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0105","doi-asserted-by":"crossref","first-page":"8343","DOI":"10.1021\/jm200762g","article-title":"Evaluation of 18F-labeled benzodioxine piperazine-based dopamine D4 receptor ligands: Lipophilicity as a determinate of nonspecific binding","volume":"54","author":"K\u00fcgler","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0110","unstructured":". Kong JY, Park WK, Cho H, Jeong D, Choi G, Koh HY, Kim SH, Pae AN, Cho YS, Cha JH (2007) Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same. Patent WO2008108517A2."},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0115","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/jm991098z","article-title":"Conjugated enynes as nonaromatic catechol bioisosteres:synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D3 subtype","volume":"43","author":"H\u00fcbner","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0120","first-page":"920","article-title":"Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2A and D2B subtypes in a heterologous cell line","volume":"6","author":"Hayes","year":"1992","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0130","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1471-4159.1995.65031157.x","article-title":"Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants","volume":"65","author":"Asghari","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0140","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1021\/acs.jmedchem.6b01857","article-title":"Discovery of G protein-biased dopaminergics with a pyrazolo[1,5-a]pyridine substructure","volume":"60","author":"M\u00f6ller","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0145","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.nucmedbio.2003.10.007","article-title":"Binding of tritiated and radioiodinated ZM241,385 to brain A2A adenosine receptors","volume":"31","author":"Sihver","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1021\/ci00053a005","article-title":"Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions","volume":"27","author":"Ghose","year":"1987","journal-title":"J Chem Inf Comput Sci"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10822-005-8694-y","article-title":"Virtual computational chemistry laboratory\u2013design and description","volume":"19","author":"Tetko","year":"2005","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0165","unstructured":"Chemicalize was used for prediction of LogP & LogD values. (Accessed July 26, 2020); Available online: http:\/\/www.chemaxon.com."},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0170","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1021\/jm9600712","article-title":"3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine:an antagonist with high affinity and selectivity for the human dopamine D4 receptor","volume":"39","author":"Kulagowski","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0702849","article-title":"Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells","volume":"128","author":"Gazi","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0960-894X(98)00692-1","article-title":"Azaindole derivatives with high affinity for the dopamine D4 receptor: synthesis, ligand binding studies and comparison of molecular electrostatic potential maps","volume":"9","author":"L\u00f6ber","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0185","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1021\/jm015522j","article-title":"Rationally based efficacy tuning of selective dopamine D4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1- ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213)","volume":"44","author":"L\u00f6ber","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00213-004-1782-1","article-title":"FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia","volume":"175","author":"Boeckler","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0195","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1021\/jm030505a","article-title":"Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction","volume":"47","author":"Cowart","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0200","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1073\/pnas.0308292101","article-title":"Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats","volume":"101","author":"Brioni","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0205","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1021\/jm060166w","article-title":"2-[(4-Phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-Methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist","volume":"49","author":"Enguehard-Gueiffier","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0210","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.tetlet.2012.02.079","article-title":"Deformylation of indole and azaindole-3-carboxaldehydes using anthranilamide and solid acid heterogeneous catalyst via quinazolinone intermediate","volume":"53","author":"Yadav","year":"2012","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0215","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1021\/jm500510f","volume":"57","author":"Jia","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0220","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1021\/jo800356q","article-title":"Concise synthesis of (S)-N-BOC-2-hydroxymethylmorpholine and (S)-N-BOC-morpholine-2-carboxylic acid","volume":"73","author":"Henegar","year":"2008","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0225","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1021\/jo0345751","article-title":"Use of sonication for the coupling of sterically hindered substrates in the phenolic Mitsunobu reaction","volume":"68","author":"Lepore","year":"2003","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0230","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/chem.201604633","article-title":"Alcohol-enhanced cu-mediated radiofluorination","volume":"23","author":"Zischler","year":"2017","journal-title":"Chem A Eur J"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(96)00235-5","article-title":"Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies","volume":"45","author":"Defagot","year":"1997","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0006-8993(96)01422-9","article-title":"Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera","volume":"752","author":"Ariano","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0245","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1021\/jm701375u","article-title":"Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-a]pyridine-based dopamine D4 receptor ligands: discovery of an inverse agonist radioligand for PET","volume":"51","author":"Prante","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2020.07.004_bb0250","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-3565(24)36885-5","article-title":"II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1","volume":"282","author":"Primus","year":"1997","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805120301955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805120301955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:35:12Z","timestamp":1760848512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805120301955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":50,"alternative-id":["S0969805120301955"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2020.07.004","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiosynthesis and evaluation of 18F-labeled dopamine D4-receptor ligands","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2020.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}